SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
DENVER, Dec. 04, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will hold a conference call to discuss business progress and updates.
丹佛，2024年12月4日（GLOBE NEWSWIRE）——開發專有解決方案以減少重要器官炎症後果的商業階段醫療器械公司海星醫療控股公司（納斯達克股票代碼：ICU）宣佈，管理層將舉行電話會議，討論業務進展和最新情況。
| Date/Time: | Wednesday, December 11, 4:30 p.m. ET / 1:30 p.m. PT |
| Pre-Registration: | Participants can pre-register for the conference call here: |
| Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. | |
| Dial In: | Those who choose not to pre-register can access the live conference call by dialing the following and requesting the SeaStar Medical call: |
| 866-777-2509 within the U.S. | |
| 412-317-5413 from outside the U.S. |
| 日期/時間： | 美國東部時間 12 月 11 日星期三下午 4:30 /太平洋時間下午 1:30 |
| 預註冊： | 參與者可以在此處預註冊電話會議： |
| 預註冊的來電者將獲得會議密碼和唯一的PIN碼，以立即訪問電話並繞過直播接線員。參與者可以隨時進行預註冊，包括通話開始之前和之後。 | |
| 撥入： | 那些選擇不預註冊的人可以通過撥打以下電話並申請SeaStar Medical電話來參加實時電話會議： |
| 美國境內 866-777-2509 | |
| 來自美國以外的 412-317-5413 |
The live webcast of the conference call also will be available here. A replay of the call will be available for 48 hours beginning two hours after its completion by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 3855739. The webcast will also be archived here.
電話會議的網絡直播也將在這裏播出。從電話會議結束兩小時起，將在48小時內重播電話會議，從美國境內撥打877-344-7529，從加拿大撥打855-669-9658或從美國境外撥打412-317-0088，然後輸入會議編號3855739。網絡直播也將存檔在這裏。
About SeaStar Medical
SeaStar Medical is a commercial-stage medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical's novel technologies rely on science and innovation to provide life-saving solutions to critically ill patients. The Company is developing and commercializing cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. For more information visit or visit us on LinkedIn or X.
關於海星醫療
SeaStar Medical是一家處於商業階段的醫療技術公司，正在重新定義體外療法如何減少過度炎症對重要器官的影響。SeaStar Medical的新技術依靠科學和創新爲危重患者提供救生解決方案。該公司正在開發和商業化以細胞爲導向的體外療法，這些療法靶向效應細胞，這些效應細胞會導致全身性炎症，造成直接組織損傷，並分泌一系列促炎細胞因數，從而引發和傳播不平衡的免疫反應。欲了解更多信息，請訪問或在 LinkedIn 或 X 上訪問我們。
Contact:
聯繫人：
Alliance Advisors IR
Jody Cain
(310) 691-7100
Jcain@allianceadvisors.com
聯盟顧問投資者關係
喬迪·凱恩
(310) 691-7100
Jcain@allianceadvisors.com
# # #
# # #
